The possible increase in total and low-density lipoprotein cholesterol
following severe restriction of dietary NaCl was reported in 1990 and
and 1991 from three experiments, one in the United States and two in
Germany. Each of these experiments lasted only 1 week. To evaluate the
clinical side effects we analyzed data collected from patients who co
mpleted a course of NaCl-restricted weight reduction at the Duke Diet
and Fitness Center. Observations of lipid changes are not available fo
r periods of less than 3 weeks; however, we were able to collect data
on lipid and lipoprotein changes from 556 participants 25 days after t
hey were referred for weight reduction. Total cholesterol, low-density
lipoprotein cholesterol, and triglyceride levels returned to normal i
n the majority of obese patients. In our slightly longer observation p
eriod in patients on a 1000 mg NaCl restricted diet we found no eviden
ce of hyperlipidemic side effects. We believe that the hyperlipidemia
resulting from severe sodium restriction in non-hypertensive, normal-w
eight individuals is not relevant to the problem of nonpharmacological
and diuretic treatment of obese hypertensive patients. In clinically
healthy, normal-weight, normotensive individuals severe salt restricti
on serves no practical or therapeutic purpose.